Financial Statements and Related Announcement::Full Yearly Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
11-May-2017 21:46:42
Status
New
Announcement Sub Title
Full Yearly Results
Announcement Reference
SG170511OTHR31BH
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Outcome of the Board Meeting - May 11, 2017

Additional Details

For Financial Period Ended
31/03/2017